The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

NCT00247507 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Anemia
Atherosclerosis
End-Stage Renal Disease
Oxidative Stress
Pro-Inflammation

Interventions

DRUG: acetylcysteine

Sponsor

Far Eastern Memorial Hospital